Tetrahydrobiopterin in the treatment of infantile hypertrophic pyloric stenosis

Biochemical and Molecular Medicine

Volumn 62, Issue 1, 1997, Pages 101-105

  Braegger, Christian P ^a   Schwöbel, Marcus ^a   Von Känel, Jakob ^a   Werner, Ernst R ^b   Thöny, Beat ^a   Blau, Nenad ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

TETRAHYDROBIOPTERIN;

ARTICLE; CHILD; CHOLINERGIC NERVE CELL; CLINICAL ARTICLE; DRUG EFFECT; ELECTRON TRANSPORT; ENZYME ACTIVITY; FEMALE; HUMAN; HYPERTROPHIC PYLORUS STENOSIS; HYPOCHLOREMIA; INFANT; INTESTINE INNERVATION; MALE; METABOLIC ALKALOSIS; PATHOGENESIS;

EID: 0031259578     PISSN: 10773150     EISSN: None     Source Type: Journal    
DOI: 10.1006/bmme.1997.2628     Document Type: Article

References (17)

1. 1. Spicer RD. Infantile hypertrophic pyloric stenosis: A review. Br J Surg 69:128-135, 1982.
2. 2. Chung E, Curtis D, Chen G, Marsden PA, Twells R, Xu W, Gardiner M. Genetic evidence for the neuronal nitric oxide synthase gene (NOS1) as a susceptibility locus for infantile pyloric stenosis. Am J Hum Genet 58:363-370, 1996.
3. 3. Vanderwinden JM, Mailleux P, Schiffmann SN, Vanderhaeghen JJ, De Laet MH. Nitric oxide synthase activity in infantile hypertrophic pyloric stenosis. N Engl J Med 327:511-515, 1992.
4. 4. Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75:1273-1286, 1993.
5. 5. Mayer B, Klatt P, Werner ER, Schmidt K. Kinetics and mechanism of tetrahydrobiopterin-induced oxidation of nitric oxide. J Biol Chem 270:655-659, 1995.
6. 6. Marletta MA. Nitric oxide synthase structure and mechanism. J Biol Chem 268:12231-12234, 1993.
7. 7. McMillan K, Bredt DS, Hirsch DJ, Snyder SH, Clark JE, Masters BSS. Cloned, expressed rat cerebellar nitric oxide synthase contains stoichiometric amounts of heme, which binds carbon monoxide. Proc Natl Acad Sci USA 89:11141-11145, 1992.
8. 8. Dawson VL, Dawson TM. Physiological and toxicological actions of nitric oxide in the central nervous system. Adv Pharmacol 34:323-342, 1995.
9. 9. Schaffner A, Blau N, Schneemann M, Steurer J, Edgell CJS, Schoedon G. Tetrahydrobiopterin as another EDRF in man. Biochem Biophys Res Commun 205:516-523, 1994.
10. 10. Curtius HC, Blau N, Kuster T. Pterins. In Techniques in Diagnostic Human Biochemical Genetics (Hommes FA, Ed.). New York: Wiley-Liss, 1991, pp 377-396.
11. 11. Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Schmidt K, Weiss G, Wachter H. Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide-mediated formation of cyclic GMP. J Biol Chem 268:1842-1846, 1993.
12. 12. Voelker CA, Miller MJ, Zhang XJ, Eloby-Childress S, Clark DA, Pierce MR. Perinatal nitric oxide synthase inhibition retards neonatal growth by inducing hypertrophic pyloric stenosis in rats. Pediatr Res 38:768-774, 1995.
13. 13. Larson LT, Shen Z, Ekblad E, Sundler F, Alm P, Andersson KE. Lack of neuronal nitric oxide synthase in nerve fibers of aganglionic intestine: A clue to Hirschprung's disease. J Pediatr Gastroenterol Nutr 20:49-53, 1995.
14. 14. Mayer B, Werner ER. Why tetrahydrobiopterin? Adv Pharmacol 34:251-261, 1995.
15. 15. Blau N, Thöny B, Heizmann CW, Dhondt JL. Tetrahydrobiopterin deficiency: From phenotype to genotype. Pteridines 4:1-10, 1993.
16. 16. Ponzone A, Guardamagna O, Spada M, Ferraris S, Ponzone R, Kierat L, Blau N. Differential diagnosis of hyperphenylalaninemia by a combined phenylalanine-tetrahydrobiopterin loading test. Eur J Pediatr 152:655-661, 1993.
17. 17. Blau N, Thöny B, Spada M, Ponzone A. Tetrahydrobiopterin and inherited hyperphenylalaninemias. Turk J Pediatr 38:19-35, 1996.